184 related articles for article (PubMed ID: 17549733)
1. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1.
Neufert C; Becker C; Wirtz S; Fantini MC; Weigmann B; Galle PR; Neurath MF
Eur J Immunol; 2007 Jul; 37(7):1809-16. PubMed ID: 17549733
[TBL] [Abstract][Full Text] [Related]
2. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
[TBL] [Abstract][Full Text] [Related]
3. The Th17/Treg imbalance in patients with acute coronary syndrome.
Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
[TBL] [Abstract][Full Text] [Related]
4. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
5. IL-27 inhibits the development of regulatory T cells via STAT3.
Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis.
Chang JH; Kim YJ; Han SH; Kang CY
Eur J Immunol; 2009 May; 39(5):1241-51. PubMed ID: 19337996
[TBL] [Abstract][Full Text] [Related]
7. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
8. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.
Ichiyama K; Hashimoto M; Sekiya T; Nakagawa R; Wakabayashi Y; Sugiyama Y; Komai K; Saba I; Möröy T; Yoshimura A
Int Immunol; 2009 Jul; 21(7):881-9. PubMed ID: 19505891
[TBL] [Abstract][Full Text] [Related]
9. Expanding and converting regulatory T cells: a horizon for immunotherapy.
Khattar M; Chen W; Stepkowski SM
Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
11. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
[TBL] [Abstract][Full Text] [Related]
13. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
Curotto de Lafaille MA; Lafaille JJ
Immunity; 2009 May; 30(5):626-35. PubMed ID: 19464985
[TBL] [Abstract][Full Text] [Related]
14. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
Mantel PY; Kuipers H; Boyman O; Rhyner C; Ouaked N; Rückert B; Karagiannidis C; Lambrecht BN; Hendriks RW; Crameri R; Akdis CA; Blaser K; Schmidt-Weber CB
PLoS Biol; 2007 Dec; 5(12):e329. PubMed ID: 18162042
[TBL] [Abstract][Full Text] [Related]
15. Plasticity of CD4+ T cell lineage differentiation.
Zhou L; Chong MM; Littman DR
Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of IL-6 and IL-4 in driving fate revision of natural Foxp3+ regulatory T cells.
Kastner L; Dwyer D; Qin FX
J Immunol; 2010 Nov; 185(10):5778-86. PubMed ID: 20926793
[TBL] [Abstract][Full Text] [Related]
17. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.
Singh TP; Schön MP; Wallbrecht K; Michaelis K; Rinner B; Mayer G; Schmidbauer U; Strohmaier H; Wang XJ; Wolf P
J Immunol; 2010 Jun; 184(12):7257-67. PubMed ID: 20488788
[TBL] [Abstract][Full Text] [Related]
18. The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy.
Li J; Wang L; Wang S; Zhu H; Ye P; Xie A; Shen B; Liu C; Guo C; Fu Q; Zhang K; Xia J
Scand J Immunol; 2010 Apr; 71(4):298-303. PubMed ID: 20384874
[TBL] [Abstract][Full Text] [Related]
19. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
20. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
